JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 45(2011) N 3 p. 466-471;
D.A. Shirokov1*, V.V. Ryabichenko1, R.I. Akishina1, T.P. Ospel'nikova2, A.V. Glazunov1, G.G. Chestukhina1, V.P. Veiko1

Development of Hybrid Human Interferon Alfa-2 Strain-Producers and the Use of Enteropeptidase for Production of N-Terminal Methionine-Free Interferons

1Institute of Genetics and Selection of Industrial Microorganisms, Moscow, 117545 Russia
2Gamaleya Scientific Research Institute of Epidemiology and Microbiology, Russian Academy of Medical Sciences, Moscow, 123098 Russia

*mielnir@gmail.com
Received - 2010-09-21; Accepted - 2010-10-14

We developed a technique for production of human interferon-α2a (IFN-α2a) and IFN-α2b lacking the N-terminal methionine. First of all, we constructed plasmids containing genes of hybrid IFN-α2 controlled by different promoters; the proximal part of the genes incorporated various sequences encoding the enteropeptidase cleavage site. As a result, four strains of Escherichia coli producing hybrid IFN-α2 were obtained. The protocol for IFN-α2 renaturation, cleavege of its N-terminal part, and chromatographic purification of the N-terminal methionine-free IFN-α2 was developed.

interferon- 2a, interferon- 2b, enteropeptidase, enterokinase



JMB-FOOTER RAS-JOURNALS